Prenatal Comparison

The following chart compares femMED Pregnancy with three of the leading prenatal brands. Unlike the leading brands, femMED Pregnancy does not contain any of the potentially harmful additives that are found in the leading brands.

*Leading Brand B also includes a liquid gelcap in their prenatal package that was not included in this comparison.

**Leading Brand C also includes digestive enzymes which were not included for comparison purposes in the above chart.

Non-Medicinal Ingredients (excipients) are various synthetic fillers used in making many nutritional or “natural” supplements. They are added to give the desired consistency or form for making tablets. Tablets cannot be manufactured without the use of excipients. Some common excipients are binders such as hydrogenated oils, fillers such as talc or corn starch, lubricants like magnesium stearate, and coloring and flavoring agents such as fructose or malt dextrose.

BHT
The Environmental Working Group classifies BHT as a skin, liver and kidney toxicant. We store it in the liver and also in fat, which is why thin people are more at risk for damage. Studies show it promotes cancer and tumor growth. Some people have difficulty metabolizing BHT and experience behavior changes as well as recognizable health changes Reference: Environmental Working  Group, http://www.ewg.org/node/26112

FD&C red no. 40
FD&C red no. 40 In Europe, Allura Red AC is not recommended for consumption by children. It is banned in the UK, Denmark, Belgium, France, Switzerland, and Sweden.The European Union approves Allura Red AC as a food colorant, but EU countries’ local laws banning food colorants are preserved. In Norway, it was banned between 1978 and 2001, a period in which azo dyes were only legally used in alcoholic beverages and some fish products.

Sodium benzoate
In combination with ascorbic acid (vitamin C, E300), sodium benzoate and potassium benzoate may form benzene,[8] a known carcinogen.

Titanium dioxide
Titanium dioxide has recently been classified by the International Agency for Research on Cancer (IARC) as an IARC Group 2B carcinogen ”possibly carcinogen to humans”. August 2006